Product NDC: | 0430-0145 |
Proprietary Name: | femhrt |
Non Proprietary Name: | norethindrone acetate/ethinyl estradiol |
Active Ingredient(s): | 2.5; .5 ug/1; mg/1 & nbsp; norethindrone acetate/ethinyl estradiol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0430-0145 |
Labeler Name: | Warner Chilcott (US), LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021065 |
Marketing Category: | NDA |
Start Marketing Date: | 20091001 |
Package NDC: | 0430-0145-14 |
Package Description: | 72 CARTON in 1 CASE (0430-0145-14) > 5 POUCH in 1 CARTON > 1 BLISTER PACK in 1 POUCH > 28 TABLET in 1 BLISTER PACK |
NDC Code | 0430-0145-14 |
Proprietary Name | femhrt |
Package Description | 72 CARTON in 1 CASE (0430-0145-14) > 5 POUCH in 1 CARTON > 1 BLISTER PACK in 1 POUCH > 28 TABLET in 1 BLISTER PACK |
Product NDC | 0430-0145 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | norethindrone acetate/ethinyl estradiol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20091001 |
Marketing Category Name | NDA |
Labeler Name | Warner Chilcott (US), LLC |
Substance Name | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
Strength Number | 2.5; .5 |
Strength Unit | ug/1; mg/1 |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |